Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFLAZACORT for Rheumatoid arthritis: Side Effects & Safety Data

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

There are 29 adverse event reports in the FDA FAERS database where DEFLAZACORT was used for Rheumatoid arthritis.

Most Reported Side Effects for DEFLAZACORT

Side Effect Reports % Deaths Hosp.
Weight increased 468 12.2% 1 22
Off label use 315 8.2% 9 42
Fall 206 5.4% 5 41
Vomiting 139 3.6% 0 20
Nasopharyngitis 134 3.5% 1 10
Abnormal behaviour 129 3.4% 0 8
Influenza 120 3.1% 2 16
Rash 114 3.0% 2 16
Headache 104 2.7% 1 8
Pyrexia 104 2.7% 4 23
Abdominal pain upper 103 2.7% 0 8
Product dose omission 99 2.6% 0 14
Weight decreased 98 2.6% 0 10
Anger 97 2.5% 0 4
Increased appetite 95 2.5% 0 5

Other Indications for DEFLAZACORT

Muscular dystrophy (1,542) Duchenne muscular dystrophy (1,446) Product used for unknown indication (508) Becker's muscular dystrophy (186) Asthma (33) Urticaria chronic (21) Immunosuppressant drug therapy (20) Muscle disorder (14) Juvenile idiopathic arthritis (12) Pulmonary sarcoidosis (12)

Other Drugs Used for Rheumatoid arthritis

ETANERCEPT (186,585) ADALIMUMAB (154,287) METHOTREXATE (84,654) TOFACITINIB (77,765) ABATACEPT (75,236) TOCILIZUMAB (55,449) CERTOLIZUMAB PEGOL (47,602) RITUXIMAB (40,017) UPADACITINIB (33,555) GOLIMUMAB (31,947)

Related Pages

DEFLAZACORT Full Profile All Rheumatoid arthritis Drugs DEFLAZACORT Demographics DEFLAZACORT Timeline